Attention Readers: Did you miss it? Yesterday Manward’s Alpesh Patel went rogue and revealed his shocking findings from using artificial intelligence to target big money in the stock market.

Click here to learn how an investing model using ChatGPT could have generated 512% over a 15-month stretch that included the tough market in 2022.

Good Morning Wake-up Watchlisters! While you’re sipping coffee you’ll see stocks were mixed on Thursday. The latest CPI numbers show inflation cooled slightly, and arrived before the Federal Reserve meets next week to decide if another interest rate increase is needed to reduce inflation.

The Fed’s decisions have caused volatility in the markets, but that doesn’t mean you still can’t make winning trades. Our Head Trading Tactician Bryan Bottarelli closed three triple-digit winners in the last three weeks, including a 133% overnight gain on ORCL this week.

Click here learn how overnight trading could double your money in less than 24 hours.

Here’s a look at the top-moving stocks this morning.

AMC Entertainment Holdings (NYSE: AMC)

AMC Entertainment is up 8.62% premarket after raising about $325.5 million through the sale of 40 million shares, a move that it said would address a cash crunch as the movie-theater industry rebounds. The offering, which began Sept. 6, sold stock at an average price of $8.14 a share, the cinema chain said in a statement Wednesday.

Citigroup Inc. (NYSE: C)

Citigroup is up 0.59% premarket after CEO Jane Fraser announced a new reorganization plan. The company, which currently operates with two divisions, will undergo a transformation into five separate divisions, all directly reporting to the CEO. Fraser says the reorganization will streamline the business and “increase accountability.”

Alnylam Pharmaceuticals (Nasdaq: ALNY)

Alnylam is down 5.74% premarket after its stock was halted on Wednesday as the FDA advisory panel reviews treatment for the Cardiomyopathy of ATTR Amyloidosis. The FDA later backed the expanded use of Alnylam Pharmaceuticals’ gene silencing drug to treat a type of heart disease associated with a rare organ-damaging disorder.

Those are the biggest stock movers for today.

Happy trading!

The Wake-Up Watchlist Research Team